|
시장보고서
상품코드
1457949
PCR 기술 시장 : 시장 규모, 점유율 분석, 산업 수요 예측(-2030년)PCR Technologies Market Size and Share Analysis by Product, Technique, Application, End User - Global Industry Demand Forecast to 2030 |
||||||
세계의 PCR 기술(PCR Technologies) 시장은 8.4%의 CAGR로 추이하며 성장 할 것으로 예상되며, 2023년에 137억 930만 달러에서, 2030년에는 236억 7,250만 달러에 이를 전망입니다.
이 성장의 배경에는 유전성 질환과 감염의 발생이 증가하고 진단 기술을 향상시키기 위한 자금이 증가하고 있을 수 있습니다. 또한, 질병의 조기 진단에 대한 의식 증가와 제품의 개발은 이 업계의 확대를 더욱 강화할 것입니다.
북미가 시장을 선도
북미는 2023년에 40%의 점유율을 획득해 업계를 선도하고 있으며, 지난 10년 동안 최대로 지속될 것으로 보입니다. 이는 감염의 유행이 증가하고 있는 것, 주요 기업이 개선된 PCR 장비 및 소모품을 도입하고 있는 것, 의료 인프라가 발전하고 있는 것 등에 근거합니다.
부문별 통찰
2023년, 시약 및 소모품 카테고리는 70%의 점유율로 업계 최대의 점유율을 차지해, 지난 10년간도 최대를 기록했습니다. 이는 PCR 검사에 시약뿐만 아니라 소모품도 정기적으로 사용되기 때문입니다.
실시간 PCR 카테고리는 2023년에 업계를 선도해 향후 몇 년간은 더욱 8%라는 현저한 속도로 진보할 것으로 보입니다. 유전자 발현 분석, 진단 테스트 개발, 암의 표현형 해석을 포함한 다양한 용도로 세계적으로 널리 채택되고 있는 방법입니다.
진단 카테고리가 가장 큰 점유율을 차지합니다. 이는 PCR 검사가 특정 유전적 변화와 감염을 진단하는 매우 정확한 수단이기 때문입니다.
세계의 PCR 기술(PCR Technologies) 시장에 대해 분석했으며, 시장의 기본 구조/최신 정세/주요 촉진·억제 요인/세계 전체 및 지역별·주요 국가별 시장 규모 동향 전망(금액 기준, 2017-2030년)/제품별·기술별·용도별·최종 사용자별 상세 동향/현재 시장 경쟁 구도/주요 기업 프로파일 등 정보를 전해드립니다.
목차
제1장 조사 범위
제2장 조사 방법
제3장 주요 요약
제4장 시장 지표
제5장 산업 전망
- 시장 역학
- 동향
- 성장 촉진 요인
- 억제 요인/과제
- 성장 촉진 요인/억제 요인의 영향 분석
- COVID-19의 영향
- Porter's Five Forces 분석
제6장 시장
- 개요
- 시장 매출 : 제품별(2017-2030년)
- 시장 매출 : 기술별(2017-2030년)
- 시장 매출 : 용도별(2017-2030년)
- 시장 매출 : 최종 사용자별(2017-2030년)
- 시장 매출 : 지역별(2017-2030년)
제7장 북미 시장
- 개요
- 시장 매출 : 제품별(2017-2030년)
- 시장 매출 : 기술별(2017-2030년)
- 시장 매출 : 용도별(2017-2030년)
- 시장 매출 : 최종 사용자별(2017-2030년)
- 시장 매출 : 국가별(2017-2030년)
제8장 유럽 시장
제9장 아시아 태평양 시장
제10장 남미 시장
제11장 중동 및 아프리카(MEA) 시장
제12장 미국 시장
- 개요
- 시장 매출 : 제품별(2017-2030년)
- 시장 매출 : 기술별(2017-2030년)
- 시장 매출 : 용도별(2017-2030년)
- 시장 매출 : 최종 사용자별(2017-2030년)
제13장 캐나다 시장
제14장 독일 시장
제15장 프랑스 시장
제16장 영국 시장
제17장 이탈리아 시장
제18장 스페인 시장
제19장 일본 시장
제20장 중국 시장
제21장 인도 시장
제22장 호주 시장
제23장 한국 시장
제24장 브라질 시장
제25장 멕시코 시장
제26장 사우디아라비아 시장
제27장 남아프리카 시장
제28장 아랍에미리트(UAE) 시장
제29장 경쟁 구도
- 시장 진출기업 및 제공 제품 및 서비스 목록
- 주요 기업의 경쟁 벤치마킹
- 주요 기업의 제품 벤치마킹
- 최근의 전략 전개 상황
제30장 기업 프로파일
- F. Hoffmann-La Roche AG
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories Inc.
- QIAGEN NV
- Takara Bio USA Inc.
- Agilent Technologies Inc.
- Standard BioTools Inc.
- Danaher Corporation
- Abbott Laboratories
- Merck Life Science Private Limited
- Becton, Dickinson and Company
- Eppendorf AG
제31장 부록
LYJ 24.04.18The PCR technologies market generated USD 13,709.3 million in 2023, which will increase to USD 23,672.5 million, powering at an 8.4% CAGR, by 2030.
The growth is because of the increasing genetic disorders and infectious disease occurrence and rising funding to improve diagnostic technologies. Furthermore, the rising consciousness about early disease diagnosis and development in products will further assist this industry expansion.
The surging need for digital PCR kits and assays, consumables, and reagents, is a major driver for this industry, particularly since the pandemic. As the pandemic broke out, the need for digital PCR tests from life sciences and biotechnology firms substantially increased.
PCR tests were performed in various kinds of settings, from hospitals and airports to shopping malls and stadia, to detect and quarantine patients with the virus.
Additionally, COVID-19 is an important factor for the acceptance of the PCR technology as it was made a mandatory test for flyers across various nations.
The Indian government, in December 2022, made RT-PCR testing for COVID-19 compulsory for passengers coming from China, Japan, Hong Kong, Thailand, Singapore, and South Korea from January 2023 onward.
Moreover, France, in January 2023, prolonged its mandate for COVID-19 tests for people arriving from China. Further, France has urged the other 26 EU member states to test Chinese travelers for the virus.
The U.S. has also placed compulsory COVID-19 tests for individuals arriving from China. Additionally, the U.S. Centers for Disease Control and Prevention said that the nation's citizens should hold plans to travel to Hong Kong, Macau, and China until further notice.
North America is Leading Market
North America led the industry in 2023, with a 40% share, and it will remain the largest throughout this decade. This can be because of the increasing prevalence of infectious diseases, the introduction of improved PCR instruments and consumables by the key players, and the development of the healthcare infrastructure.
Moreover, the growing partnerships between businesses are also aiding the industry expansion.
For example, Takara Bio USA Inc., in October 2022, collaborated with BioExcel Diagnostics Laboratory to develop a new technique for detecting infectious illnesses that result in syndromes and authenticate its efficiency.
Segmentation Insights
In 2023, the reagents and consumables category was the largest contributor to the industry, with a 70% share, and it will remain the largest during this decade. This can be ascribed to the regular use of consumables as well as reagents for PCR testing.
The real-time PCR category led the industry in 2023, and will further advance at a significant rate, of 8%, in the coming years. It is an extensively employed method globally for different applications, including gene expression analysis, diagnostic test development, and cancer phenotyping.
The diagnostics category accounted for the largest share. This is because PCR tests are a very precise means to diagnose specific genetic changes and infectious ailments.
Competition Analysis
Major players in this industry are entering into mergers and acquisitions to reach more people, increase their revenue, and improve the technology of their products.
Bio-Rad Laboratories Inc., in August 2022, signed a deal to acquire all the outstanding shares of Curiosity Diagnostics Sp. Z. o. o.'s for USD 170 million.
The contract provided Bio-Rad access to Curiosity Diagnostics' under-development sample-to-answer, rapid polymerase chain reaction system for molecular diagnostics.
With the rising funding to improve diagnostic technologies, the PCR technologies industry will grow significantly in the coming years.
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by product
- 1.4.2. Market size breakdown, by technique
- 1.4.3. Market size breakdown, by application
- 1.4.4. Market size breakdown, by end user
- 1.4.5. Market size breakdown, by region
- 1.4.6. Market size breakdown, by country
- 1.5. Market Data Reporting Unit
- 1.5.1. Value
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
- 5.1. Market Dynamics
- 5.1.1. Trends
- 5.1.2. Drivers
- 5.1.3. Restraints/challenges
- 5.1.4. Impact analysis of drivers/restraints
- 5.2. Impact of COVID-19
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Bargaining power of buyers
- 5.3.2. Bargaining power of suppliers
- 5.3.3. Threat of new entrants
- 5.3.4. Intensity of rivalry
- 5.3.5. Threat of substitutes
Chapter 6. Global Market
- 6.1. Overview
- 6.2. Market Revenue, by Product (2017-2030)
- 6.3. Market Revenue, by Technique (2017-2030)
- 6.4. Market Revenue, by Application (2017-2030)
- 6.5. Market Revenue, by End User (2017-2030)
- 6.6. Market Revenue, by Region (2017-2030)
Chapter 7. North America Market
- 7.1. Overview
- 7.2. Market Revenue, by Product (2017-2030)
- 7.3. Market Revenue, by Technique (2017-2030)
- 7.4. Market Revenue, by Application (2017-2030)
- 7.5. Market Revenue, by End User (2017-2030)
- 7.6. Market Revenue, by Country (2017-2030)
Chapter 8. Europe Market
- 8.1. Overview
- 8.2. Market Revenue, by Product (2017-2030)
- 8.3. Market Revenue, by Technique (2017-2030)
- 8.4. Market Revenue, by Application (2017-2030)
- 8.5. Market Revenue, by End User (2017-2030)
- 8.6. Market Revenue, by Country (2017-2030)
Chapter 9. APAC Market
- 9.1. Overview
- 9.2. Market Revenue, by Product (2017-2030)
- 9.3. Market Revenue, by Technique (2017-2030)
- 9.4. Market Revenue, by Application (2017-2030)
- 9.5. Market Revenue, by End User (2017-2030)
- 9.6. Market Revenue, by Country (2017-2030)
Chapter 10. LATAM Market
- 10.1. Overview
- 10.2. Market Revenue, by Product (2017-2030)
- 10.3. Market Revenue, by Technique (2017-2030)
- 10.4. Market Revenue, by Application (2017-2030)
- 10.5. Market Revenue, by End User (2017-2030)
- 10.6. Market Revenue, by Country (2017-2030)
Chapter 11. MEA Market
- 11.1. Overview
- 11.2. Market Revenue, by Product (2017-2030)
- 11.3. Market Revenue, by Technique (2017-2030)
- 11.4. Market Revenue, by Application (2017-2030)
- 11.5. Market Revenue, by End User (2017-2030)
- 11.6. Market Revenue, by Country (2017-2030)
Chapter 12. U.S. Market
- 12.1. Overview
- 12.2. Market Revenue, by Product (2017-2030)
- 12.3. Market Revenue, by Technique (2017-2030)
- 12.4. Market Revenue, by Application (2017-2030)
- 12.5. Market Revenue, by End User (2017-2030)
Chapter 13. Canada Market
- 13.1. Overview
- 13.2. Market Revenue, by Product (2017-2030)
- 13.3. Market Revenue, by Technique (2017-2030)
- 13.4. Market Revenue, by Application (2017-2030)
- 13.5. Market Revenue, by End User (2017-2030)
Chapter 14. Germany Market
- 14.1. Overview
- 14.2. Market Revenue, by Product (2017-2030)
- 14.3. Market Revenue, by Technique (2017-2030)
- 14.4. Market Revenue, by Application (2017-2030)
- 14.5. Market Revenue, by End User (2017-2030)
Chapter 15. France Market
- 15.1. Overview
- 15.2. Market Revenue, by Product (2017-2030)
- 15.3. Market Revenue, by Technique (2017-2030)
- 15.4. Market Revenue, by Application (2017-2030)
- 15.5. Market Revenue, by End User (2017-2030)
Chapter 16. U.K. Market
- 16.1. Overview
- 16.2. Market Revenue, by Product (2017-2030)
- 16.3. Market Revenue, by Technique (2017-2030)
- 16.4. Market Revenue, by Application (2017-2030)
- 16.5. Market Revenue, by End User (2017-2030)
Chapter 17. Italy Market
- 17.1. Overview
- 17.2. Market Revenue, by Product (2017-2030)
- 17.3. Market Revenue, by Technique (2017-2030)
- 17.4. Market Revenue, by Application (2017-2030)
- 17.5. Market Revenue, by End User (2017-2030)
Chapter 18. Spain Market
- 18.1. Overview
- 18.2. Market Revenue, by Product (2017-2030)
- 18.3. Market Revenue, by Technique (2017-2030)
- 18.4. Market Revenue, by Application (2017-2030)
- 18.5. Market Revenue, by End User (2017-2030)
Chapter 19. Japan Market
- 19.1. Overview
- 19.2. Market Revenue, by Product (2017-2030)
- 19.3. Market Revenue, by Technique (2017-2030)
- 19.4. Market Revenue, by Application (2017-2030)
- 19.5. Market Revenue, by End User (2017-2030)
Chapter 20. China Market
- 20.1. Overview
- 20.2. Market Revenue, by Product (2017-2030)
- 20.3. Market Revenue, by Technique (2017-2030)
- 20.4. Market Revenue, by Application (2017-2030)
- 20.5. Market Revenue, by End User (2017-2030)
Chapter 21. India Market
- 21.1. Overview
- 21.2. Market Revenue, by Product (2017-2030)
- 21.3. Market Revenue, by Technique (2017-2030)
- 21.4. Market Revenue, by Application (2017-2030)
- 21.5. Market Revenue, by End User (2017-2030)
Chapter 22. Australia Market
- 22.1. Overview
- 22.2. Market Revenue, by Product (2017-2030)
- 22.3. Market Revenue, by Technique (2017-2030)
- 22.4. Market Revenue, by Application (2017-2030)
- 22.5. Market Revenue, by End User (2017-2030)
Chapter 23. South Korea Market
- 23.1. Overview
- 23.2. Market Revenue, by Product (2017-2030)
- 23.3. Market Revenue, by Technique (2017-2030)
- 23.4. Market Revenue, by Application (2017-2030)
- 23.5. Market Revenue, by End User (2017-2030)
Chapter 24. Brazil Market
- 24.1. Overview
- 24.2. Market Revenue, by Product (2017-2030)
- 24.3. Market Revenue, by Technique (2017-2030)
- 24.4. Market Revenue, by Application (2017-2030)
- 24.5. Market Revenue, by End User (2017-2030)
Chapter 25. Mexico Market
- 25.1. Overview
- 25.2. Market Revenue, by Product (2017-2030)
- 25.3. Market Revenue, by Technique (2017-2030)
- 25.4. Market Revenue, by Application (2017-2030)
- 25.5. Market Revenue, by End User (2017-2030)
Chapter 26. Saudi Arabia Market
- 26.1. Overview
- 26.2. Market Revenue, by Product (2017-2030)
- 26.3. Market Revenue, by Technique (2017-2030)
- 26.4. Market Revenue, by Application (2017-2030)
- 26.5. Market Revenue, by End User (2017-2030)
Chapter 27. South Africa Market
- 27.1. Overview
- 27.2. Market Revenue, by Product (2017-2030)
- 27.3. Market Revenue, by Technique (2017-2030)
- 27.4. Market Revenue, by Application (2017-2030)
- 27.5. Market Revenue, by End User (2017-2030)
Chapter 28. U.A.E. Market
- 28.1. Overview
- 28.2. Market Revenue, by Product (2017-2030)
- 28.3. Market Revenue, by Technique (2017-2030)
- 28.4. Market Revenue, by Application (2017-2030)
- 28.5. Market Revenue, by End User (2017-2030)
Chapter 29. Competitive Landscape
- 29.1. List of Market Players and their Offerings
- 29.2. Competitive Benchmarking of Key Players
- 29.3. Product Benchmarking of Key Players
- 29.4. Recent Strategic Developments
Chapter 30. Company Profiles
- 30.1. F. Hoffmann-La Roche AG
- 30.1.1. Business overview
- 30.1.2. Product and service offerings
- 30.1.3. Key financial summary
- 30.2. Thermo Fisher Scientific Inc.
- 30.2.1. Business overview
- 30.2.2. Product and service offerings
- 30.2.3. Key financial summary
- 30.3. Bio-Rad Laboratories Inc.
- 30.3.1. Business overview
- 30.3.2. Product and service offerings
- 30.3.3. Key financial summary
- 30.4. QIAGEN N.V.
- 30.4.1. Business overview
- 30.4.2. Product and service offerings
- 30.4.3. Key financial summary
- 30.5. Takara Bio USA Inc.
- 30.5.1. Business overview
- 30.5.2. Product and service offerings
- 30.5.3. Key financial summary
- 30.6. Agilent Technologies Inc.
- 30.6.1. Business overview
- 30.6.2. Product and service offerings
- 30.6.3. Key financial summary
- 30.7. Standard BioTools Inc.
- 30.7.1. Business overview
- 30.7.2. Product and service offerings
- 30.7.3. Key financial summary
- 30.8. Danaher Corporation
- 30.8.1. Business overview
- 30.8.2. Product and service offerings
- 30.8.3. Key financial summary
- 30.9. Abbott Laboratories
- 30.9.1. Business overview
- 30.9.2. Product and service offerings
- 30.9.3. Key financial summary
- 30.10. Merck Life Science Private Limited
- 30.10.1. Business overview
- 30.10.2. Product and service offerings
- 30.10.3. Key financial summary
- 30.11. Becton, Dickinson and Company
- 30.11.1. Business overview
- 30.11.2. Product and service offerings
- 30.11.3. Key financial summary
- 30.12. Eppendorf AG
- 30.12.1. Business overview
- 30.12.2. Product and service offerings
- 30.12.3. Key financial summary
Chapter 31. Appendix
- 31.1. Abbreviations
- 31.2. Sources and References
- 31.3. Related Reports
